OUTPATIENT ADMINISTRATION OF MOSUNETUZUMAB IN US COMMUNITY PRACTICE SETTINGS: PERSPECTIVES AND LEARNINGS FROM THE PHASE II MORNINGSUN STUDY

Category Primary study
Conference17th International Conference on Malignant Lymphoma
Year 2023
This article has no abstract
Epistemonikos ID: f3d008ea50e9c3faa07810c04d73bdb4ad2c5e7d
First added on: May 18, 2026